SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'LVY'


List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4CI1_B_EF2B1429_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		10 / 10 ASN B 353
PRO B 354
HIS B 355
HIS B 359
HIS B 380
SER B 381
TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-4.5A)
LVY  B1429 ( 4.8A)
LVY  B1429 (-4.0A)
LVY  B1429 (-3.8A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.08A 4ci1B-4ci2B:
58.1		 4ci1B-4ci2B:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4CI1_B_EF2B1429_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		6 / 10 ASN B 353
PRO B 354
HIS B 359
HIS B 380
SER B 381
PHE B 383
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 ( 4.8A)
LVY  B1429 (-4.0A)
LVY  B1429 (-3.8A)
None
 1.36A 4ci1B-4ci2B:
58.1		 4ci1B-4ci2B:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CI1_B_EF2B1429_1
(PROTEIN CEREBLON)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		6 / 10 ASN A  50
PRO A  51
SER A  78
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.0A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.40A 4ci1B-4v30A:
0.0		 4ci1B-4v30A:
16.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CI2_B_LVYB1429_1
(PROTEIN CEREBLON)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		6 / 9 ASN A  50
PRO A  51
SER A  78
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.0A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.42A 4ci2B-4v30A:
0.0		 4ci2B-4v30A:
16.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4CI3_B_Y70B1429_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		10 / 10 ASN B 353
PRO B 354
HIS B 355
HIS B 359
HIS B 380
SER B 381
TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-4.5A)
LVY  B1429 ( 4.8A)
LVY  B1429 (-4.0A)
LVY  B1429 (-3.8A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.12A 4ci3B-4ci2B:
58.3		 4ci3B-4ci2B:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CI3_B_Y70B1429_1
(PROTEIN CEREBLON)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		6 / 10 ASN A  50
PRO A  51
SER A  78
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.0A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.40A 4ci3B-4v30A:
0.0		 4ci3B-4v30A:
16.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4TZ4_C_LVYC502_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		9 / 9 ASN B 353
PRO B 354
HIS B 355
HIS B 380
SER B 381
TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-4.5A)
LVY  B1429 (-4.0A)
LVY  B1429 (-3.8A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.26A 4tz4C-4ci2B:
18.0		 4tz4C-4ci2B:
87.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TZ4_C_LVYC502_1
(PROTEIN CEREBLON)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		6 / 9 ASN A  50
PRO A  51
SER A  78
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.0A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.51A 4tz4C-4v30A:
0.0		 4tz4C-4v30A:
16.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TZC_A_EF2A504_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.29A 4tzcA-4ci2B:
17.6		 4tzcA-4ci2B:
21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TZC_C_EF2C502_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.24A 4tzcC-4ci2B:
17.4		 4tzcC-4ci2B:
21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TZC_D_EF2D505_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 8 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.21A 4tzcB-4ci2B:
16.9
4tzcD-4ci2B:
16.9		 4tzcB-4ci2B:
21.88
4tzcD-4ci2B:
21.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4TZU_A_Y70A504_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.25A 4tzuA-4ci2B:
17.4		 4tzuA-4ci2B:
90.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4TZU_B_Y70B505_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 7 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.23A 4tzuB-4ci2B:
17.7
4tzuC-4ci2B:
17.5		 4tzuB-4ci2B:
90.74
4tzuC-4ci2B:
90.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4TZU_C_Y70C504_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 7 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.27A 4tzuB-4ci2B:
17.7
4tzuC-4ci2B:
17.5		 4tzuB-4ci2B:
90.74
4tzuC-4ci2B:
90.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4TZU_D_Y70D503_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.34A 4tzuD-4ci2B:
17.8		 4tzuD-4ci2B:
90.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V2Y_A_EF2A151_1
(CEREBLON ISOFORM 4)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		5 / 7 ASN B 353
PRO B 354
TRP B 382
TRP B 388
TRP B 402
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
 0.42A 4v2yA-4ci2B:
15.9		 4v2yA-4ci2B:
16.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4V2Y_A_EF2A151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.10A 4v2yA-4v30A:
24.1		 4v2yA-4v30A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V2Y_B_EF2B151_1
(CEREBLON ISOFORM 4)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		5 / 7 ASN B 353
PRO B 354
TRP B 382
TRP B 388
TRP B 402
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
 0.42A 4v2yB-4ci2B:
16.3		 4v2yB-4ci2B:
16.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4V2Y_B_EF2B151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.27A 4v2yB-4v30A:
22.6		 4v2yB-4v30A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V2Y_C_EF2C151_1
(CEREBLON ISOFORM 4)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		5 / 7 ASN B 353
PRO B 354
TRP B 382
TRP B 388
TRP B 402
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
 0.66A 4v2yC-4ci2B:
14.9		 4v2yC-4ci2B:
16.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4V2Y_C_EF2C151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.74A 4v2yC-4v30A:
20.0		 4v2yC-4v30A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V2Z_A_Y70A151_1
(CEREBLON ISOFORM 4)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		5 / 7 ASN B 353
PRO B 354
TRP B 382
TRP B 388
TRP B 402
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
 0.41A 4v2zA-4ci2B:
15.9		 4v2zA-4ci2B:
16.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4V2Z_A_Y70A151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.11A 4v2zA-4v30A:
24.2		 4v2zA-4v30A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V2Z_B_Y70B151_1
(CEREBLON ISOFORM 4)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		5 / 8 ASN B 353
PRO B 354
TRP B 382
TRP B 388
TRP B 402
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
 0.42A 4v2zB-4ci2B:
16.2		 4v2zB-4ci2B:
16.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4V2Z_B_Y70B151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		8 / 8 ASN A  50
PRO A  51
MET A  54
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
None
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.28A 4v2zB-4v30A:
22.6		 4v2zB-4v30A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V2Z_C_Y70C151_1
(CEREBLON ISOFORM 4)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		5 / 8 ASN B 353
PRO B 354
TRP B 382
TRP B 388
TRP B 402
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
 0.62A 4v2zC-4ci2B:
14.7		 4v2zC-4ci2B:
16.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4V2Z_C_Y70C151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		8 / 8 ASN A  50
PRO A  51
PHE A  56
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
None
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.76A 4v2zC-4v30A:
19.9		 4v2zC-4v30A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V30_A_LVYA151_1
(CEREBLON ISOFORM 4)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		5 / 7 ASN B 353
PRO B 354
TRP B 382
TRP B 388
TRP B 402
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
 0.45A 4v30A-4ci2B:
16.0		 4v30A-4ci2B:
16.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V30_B_LVYB151_1
(CEREBLON ISOFORM 4)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		5 / 8 ASN B 353
PRO B 354
TRP B 382
TRP B 388
TRP B 402
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
 0.42A 4v30B-4ci2B:
16.3		 4v30B-4ci2B:
16.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V30_C_LVYC151_1
(CEREBLON ISOFORM 4)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		5 / 7 ASN B 353
PRO B 354
TRP B 382
TRP B 388
TRP B 402
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
 0.58A 4v30C-4ci2B:
14.5		 4v30C-4ci2B:
16.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V32_A_EF2A151_1
(CEREBLON ISOFORM 4)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		6 / 7 ASN B 353
PRO B 354
TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.41A 4v32A-4ci2B:
15.9		 4v32A-4ci2B:
16.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4V32_A_EF2A151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		6 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.13A 4v32A-4v30A:
24.0		 4v32A-4v30A:
99.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V32_B_EF2B151_1
(CEREBLON ISOFORM 4)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		6 / 7 ASN B 353
PRO B 354
TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.46A 4v32B-4ci2B:
16.4		 4v32B-4ci2B:
16.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4V32_B_EF2B151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		6 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.30A 4v32B-4v30A:
22.6		 4v32B-4v30A:
99.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V32_C_EF2C151_1
(CEREBLON ISOFORM 4)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		6 / 7 ASN B 353
PRO B 354
TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.60A 4v32C-4ci2B:
14.5		 4v32C-4ci2B:
16.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4V32_C_EF2C151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		6 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.77A 4v32C-4v30A:
19.6		 4v32C-4v30A:
99.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AMH_A_EF2A151_1
(CEREBLON ISOFORM 4)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		5 / 7 ASN B 353
PRO B 354
TRP B 382
TRP B 388
TRP B 402
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
 0.49A 5amhA-4ci2B:
16.2		 5amhA-4ci2B:
16.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5AMH_A_EF2A151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.47A 5amhA-4v30A:
22.0		 5amhA-4v30A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AMI_A_EF2A151_1
(CEREBLON ISOFORM 4)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		5 / 7 ASN B 353
PRO B 354
TRP B 382
TRP B 388
TRP B 402
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
 0.43A 5amiA-4ci2B:
16.2		 5amiA-4ci2B:
16.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5AMI_A_EF2A151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.14A 5amiA-4v30A:
23.6		 5amiA-4v30A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AMI_B_EF2B151_1
(CEREBLON ISOFORM 4)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		6 / 8 ASN B 353
PRO B 354
SER B 381
TRP B 382
TRP B 388
TRP B 402
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-3.8A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
 0.39A 5amiB-4ci2B:
16.4		 5amiB-4ci2B:
16.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5AMI_B_EF2B151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		8 / 8 ASN A  50
PRO A  51
PHE A  77
SER A  78
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.0A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.26A 5amiB-4v30A:
22.3		 5amiB-4v30A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AMJ_A_EF2A151_1
(CEREBLON ISOFORM 4)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		5 / 7 ASN B 353
PRO B 354
TRP B 382
TRP B 388
TRP B 402
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
 0.37A 5amjA-4ci2B:
16.0		 5amjA-4ci2B:
16.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5AMJ_A_EF2A151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.17A 5amjA-4v30A:
23.4		 5amjA-4v30A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AMJ_B_EF2B151_1
(CEREBLON ISOFORM 4)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		5 / 7 ASN B 353
PRO B 354
TRP B 382
TRP B 388
TRP B 402
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
 0.39A 5amjB-4ci2B:
16.3		 5amjB-4ci2B:
16.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5AMJ_B_EF2B151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.25A 5amjB-4v30A:
22.3		 5amjB-4v30A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AMK_A_EF2A151_1
(CEREBLON ISOFORM 4)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		5 / 8 ASN B 353
PRO B 354
TRP B 382
TRP B 388
TRP B 402
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
 0.46A 5amkA-4ci2B:
16.2		 5amkA-4ci2B:
16.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5AMK_A_EF2A151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		8 / 8 ASN A  50
PRO A  51
PHE A  56
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
None
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.56A 5amkA-4v30A:
22.2		 5amkA-4v30A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AMK_B_EF2B151_1
(CEREBLON ISOFORM 4)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		5 / 7 ASN B 353
PRO B 354
TRP B 382
TRP B 388
TRP B 402
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
 0.46A 5amkB-4ci2B:
16.3		 5amkB-4ci2B:
16.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5AMK_B_EF2B151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.16A 5amkB-4v30A:
22.5		 5amkB-4v30A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5FQD_B_LVYB1438_1
(PROTEIN CEREBLON
CASEIN KINASE I
ISOFORM ALPHA)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		8 / 11 ASN B 353
PRO B 354
HIS B 355
HIS B 380
TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-4.5A)
LVY  B1429 (-4.0A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.36A 5fqdB-4ci2B:
53.5
5fqdC-4ci2B:
0.0		 5fqdB-4ci2B:
79.32
5fqdC-4ci2B:
21.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5FQD_B_LVYB1438_1
(PROTEIN CEREBLON
CASEIN KINASE I
ISOFORM ALPHA)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		6 / 11 GLU B 379
HIS B 380
TRP B 382
TRP B 388
TRP B 402
PHE B 404
 None
LVY  B1429 (-4.0A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.87A 5fqdB-4ci2B:
53.5
5fqdC-4ci2B:
0.0		 5fqdB-4ci2B:
79.32
5fqdC-4ci2B:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FQD_B_LVYB1438_1
(PROTEIN CEREBLON
CASEIN KINASE I
ISOFORM ALPHA)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		5 / 11 ASN A  50
PRO A  51
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.48A 5fqdB-4v30A:
0.0
5fqdC-4v30A:
0.0		 5fqdB-4v30A:
16.14
5fqdC-4v30A:
13.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5FQD_E_LVYE1438_1
(PROTEIN CEREBLON
CASEIN KINASE I
ISOFORM ALPHA)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		9 / 12 ASN B 353
PRO B 354
HIS B 355
HIS B 380
SER B 381
TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-4.5A)
LVY  B1429 (-4.0A)
LVY  B1429 (-3.8A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.34A 5fqdE-4ci2B:
51.1
5fqdF-4ci2B:
0.0		 5fqdE-4ci2B:
79.32
5fqdF-4ci2B:
21.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5FQD_E_LVYE1438_1
(PROTEIN CEREBLON
CASEIN KINASE I
ISOFORM ALPHA)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		7 / 12 GLU B 379
HIS B 380
SER B 381
TRP B 382
TRP B 388
TRP B 402
PHE B 404
 None
LVY  B1429 (-4.0A)
LVY  B1429 (-3.8A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.83A 5fqdE-4ci2B:
51.1
5fqdF-4ci2B:
0.0		 5fqdE-4ci2B:
79.32
5fqdF-4ci2B:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FQD_E_LVYE1438_1
(PROTEIN CEREBLON
CASEIN KINASE I
ISOFORM ALPHA)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		6 / 12 ASN A  50
PRO A  51
SER A  78
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.0A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.44A 5fqdE-4v30A:
18.6
5fqdF-4v30A:
0.0		 5fqdE-4v30A:
16.14
5fqdF-4v30A:
13.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FQD_E_LVYE1438_1
(PROTEIN CEREBLON
CASEIN KINASE I
ISOFORM ALPHA)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		5 / 12 GLU A  76
SER A  78
TRP A  79
TRP A  85
TRP A  99
 None
LVY  A 151 (-4.0A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 1.02A 5fqdE-4v30A:
18.6
5fqdF-4v30A:
0.0		 5fqdE-4v30A:
16.14
5fqdF-4v30A:
13.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OH1_A_EF2A202_0
(CEREBLON ISOFORM 4)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		5 / 7 ASN B 353
PRO B 354
TRP B 382
TRP B 388
TRP B 402
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
 0.46A 5oh1A-4ci2B:
16.0		 5oh1A-4ci2B:
12.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OH1_A_EF2A202_0
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.16A 5oh1A-4v30A:
24.1		 5oh1A-4v30A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OH1_B_EF2B202_0
(CEREBLON ISOFORM 4)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		5 / 7 ASN B 353
PRO B 354
TRP B 382
TRP B 388
TRP B 402
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
 0.52A 5oh1B-4ci2B:
16.3		 5oh1B-4ci2B:
12.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OH1_B_EF2B202_0
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.36A 5oh1B-4v30A:
22.6		 5oh1B-4v30A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OH1_C_9UQC202_0
(CEREBLON ISOFORM 4)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		5 / 8 ASN B 353
PRO B 354
TRP B 382
TRP B 388
TRP B 402
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
 0.69A 5oh1C-4ci2B:
14.7		 5oh1C-4ci2B:
16.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OH1_C_9UQC202_0
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		6 / 8 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 1.00A 5oh1C-4v30A:
19.9		 5oh1C-4v30A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OH1_C_9UQC202_0
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		5 / 8 PRO A  51
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.55A 5oh1C-4v30A:
19.9		 5oh1C-4v30A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OH3_A_9V2A202_0
(CEREBLON ISOFORM 4)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		5 / 7 ASN B 353
PRO B 354
TRP B 382
TRP B 388
TRP B 402
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
 0.38A 5oh3A-4ci2B:
16.1		 5oh3A-4ci2B:
16.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OH3_A_9V2A202_0
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.15A 5oh3A-4v30A:
24.0		 5oh3A-4v30A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OH3_B_9V2B202_0
(CEREBLON ISOFORM 4)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		5 / 7 ASN B 353
PRO B 354
TRP B 382
TRP B 388
TRP B 402
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
 0.46A 5oh3B-4ci2B:
16.4		 5oh3B-4ci2B:
16.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OH3_B_9V2B202_0
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.30A 5oh3B-4v30A:
23.0		 5oh3B-4v30A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YIZ_A_EF2A501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.27A 5yizA-4ci2B:
17.2		 5yizA-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YIZ_B_EF2B501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.20A 5yizb-4ci2B:
17.4		 5yizb-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YIZ_D_EF2D501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.27A 5yizD-4ci2B:
17.2		 5yizD-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YIZ_E_EF2E501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.20A 5yize-4ci2B:
17.7		 5yize-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YIZ_G_EF2G501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 7 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.28A 5yizG-4ci2B:
17.2
5yizY-4ci2B:
17.7		 5yizG-4ci2B:
17.79
5yizY-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YIZ_H_EF2H501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.23A 5yizh-4ci2B:
17.3		 5yizh-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YIZ_J_EF2J501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.25A 5yizJ-4ci2B:
17.5		 5yizJ-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YIZ_K_EF2K501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 7 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.23A 5yizk-4ci2B:
17.7
5yizt-4ci2B:
17.1		 5yizk-4ci2B:
17.79
5yizt-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YIZ_M_EF2M501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.22A 5yizM-4ci2B:
17.7		 5yizM-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YIZ_N_EF2N501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.24A 5yizn-4ci2B:
17.5		 5yizn-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YIZ_P_EF2P501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.19A 5yizP-4ci2B:
17.4		 5yizP-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YIZ_Q_EF2Q501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.19A 5yizq-4ci2B:
17.5		 5yizq-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YIZ_S_EF2S501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.22A 5yizS-4ci2B:
17.5		 5yizS-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YIZ_T_EF2T501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 7 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.26A 5yizk-4ci2B:
17.7
5yizt-4ci2B:
17.1		 5yizk-4ci2B:
17.79
5yizt-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YIZ_V_EF2V501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.23A 5yizV-4ci2B:
17.3		 5yizV-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YIZ_Y_EF2Y501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 7 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.21A 5yizG-4ci2B:
17.2
5yizY-4ci2B:
17.7		 5yizG-4ci2B:
17.79
5yizY-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YJ0_A_EF2A501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.26A 5yj0A-4ci2B:
17.2		 5yj0A-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YJ0_B_EF2B501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.20A 5yj0b-4ci2B:
17.4		 5yj0b-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YJ0_D_EF2D501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.28A 5yj0D-4ci2B:
17.1		 5yj0D-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YJ0_E_EF2E501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.19A 5yj0e-4ci2B:
17.7		 5yj0e-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YJ0_G_EF2G501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 7 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.27A 5yj0G-4ci2B:
17.2
5yj0Y-4ci2B:
17.7		 5yj0G-4ci2B:
17.79
5yj0Y-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YJ0_H_EF2H501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.24A 5yj0h-4ci2B:
17.3		 5yj0h-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YJ0_J_EF2J501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.27A 5yj0J-4ci2B:
17.5		 5yj0J-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YJ0_K_EF2K501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 7 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.19A 5yj0k-4ci2B:
17.8
5yj0t-4ci2B:
17.0		 5yj0k-4ci2B:
17.79
5yj0t-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YJ0_M_EF2M501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.20A 5yj0M-4ci2B:
17.7		 5yj0M-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YJ0_N_EF2N501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.26A 5yj0n-4ci2B:
17.5		 5yj0n-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YJ0_P_EF2P501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.20A 5yj0P-4ci2B:
17.5		 5yj0P-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YJ0_Q_EF2Q501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.21A 5yj0q-4ci2B:
17.5		 5yj0q-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YJ0_S_EF2S501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.21A 5yj0S-4ci2B:
17.5		 5yj0S-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YJ0_T_EF2T501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 7 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.27A 5yj0k-4ci2B:
17.8
5yj0t-4ci2B:
17.0		 5yj0k-4ci2B:
17.79
5yj0t-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YJ0_V_EF2V501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.25A 5yj0V-4ci2B:
17.3		 5yj0V-4ci2B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YJ0_Y_EF2Y501_1
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 7 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.20A 5yj0G-4ci2B:
17.2
5yj0Y-4ci2B:
17.7		 5yj0G-4ci2B:
17.79
5yj0Y-4ci2B:
17.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5YJ1_A_6ELA501_0
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.30A 5yj1A-4ci2B:
17.2		 5yj1A-4ci2B:
34.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5YJ1_B_6ELB501_0
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.25A 5yj1b-4ci2B:
17.3		 5yj1b-4ci2B:
34.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5YJ1_D_6ELD501_0
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.28A 5yj1D-4ci2B:
17.2		 5yj1D-4ci2B:
34.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5YJ1_E_6ELE501_0
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.20A 5yj1e-4ci2B:
17.4		 5yj1e-4ci2B:
34.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5YJ1_G_6ELG501_0
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 8 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.28A 5yj1G-4ci2B:
17.0
5yj1Y-4ci2B:
17.4		 5yj1G-4ci2B:
34.47
5yj1Y-4ci2B:
34.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5YJ1_G_6ELG501_0
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 8 TRP B 388
TRP B 402
PHE B 404
HIS B 355
 LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
LVY  B1429 (-4.5A)
 1.21A 5yj1G-4ci2B:
17.0
5yj1Y-4ci2B:
17.4		 5yj1G-4ci2B:
34.47
5yj1Y-4ci2B:
34.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5YJ1_H_6ELH501_0
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.24A 5yj1h-4ci2B:
17.2		 5yj1h-4ci2B:
34.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5YJ1_J_6ELJ501_0
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.25A 5yj1J-4ci2B:
17.4		 5yj1J-4ci2B:
34.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5YJ1_K_6ELK501_0
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 7 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.25A 5yj1k-4ci2B:
17.6
5yj1t-4ci2B:
17.1		 5yj1k-4ci2B:
34.47
5yj1t-4ci2B:
34.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5YJ1_M_6ELM501_0
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.22A 5yj1M-4ci2B:
17.4		 5yj1M-4ci2B:
34.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5YJ1_N_6ELN501_0
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.24A 5yj1n-4ci2B:
17.4		 5yj1n-4ci2B:
34.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5YJ1_P_6ELP501_0
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.21A 5yj1P-4ci2B:
17.3		 5yj1P-4ci2B:
34.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5YJ1_Q_6ELQ501_0
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.24A 5yj1q-4ci2B:
17.4		 5yj1q-4ci2B:
34.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5YJ1_S_6ELS501_0
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.22A 5yj1S-4ci2B:
17.4		 5yj1S-4ci2B:
34.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5YJ1_T_6ELT501_0
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 8 HIS B 355
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-4.5A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 1.19A 5yj1k-4ci2B:
17.6
5yj1t-4ci2B:
17.1		 5yj1k-4ci2B:
34.47
5yj1t-4ci2B:
34.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5YJ1_T_6ELT501_0
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 8 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.30A 5yj1k-4ci2B:
17.6
5yj1t-4ci2B:
17.1		 5yj1k-4ci2B:
34.47
5yj1t-4ci2B:
34.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5YJ1_V_6ELV501_0
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 5 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.22A 5yj1V-4ci2B:
17.2		 5yj1V-4ci2B:
34.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5YJ1_Y_6ELY501_0
(PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		4 / 7 TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.21A 5yj1G-4ci2B:
17.0
5yj1Y-4ci2B:
17.4		 5yj1G-4ci2B:
34.47
5yj1Y-4ci2B:
34.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H0F_B_Y70B502_0
(IKAROS (IKZF1)
PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		8 / 12 ASN B 353
PRO B 354
HIS B 355
HIS B 380
TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-4.5A)
LVY  B1429 (-4.0A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.43A 6h0fB-4ci2B:
29.9
6h0fC-4ci2B:
undetectable		 6h0fB-4ci2B:
46.28
6h0fC-4ci2B:
4.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H0F_B_Y70B502_0
(IKAROS (IKZF1)
PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		6 / 12 GLU B 379
HIS B 380
TRP B 382
TRP B 388
TRP B 402
PHE B 404
 None
LVY  B1429 (-4.0A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.96A 6h0fB-4ci2B:
29.9
6h0fC-4ci2B:
undetectable		 6h0fB-4ci2B:
46.28
6h0fC-4ci2B:
4.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6H0F_B_Y70B502_0
(IKAROS (IKZF1)
PROTEIN CEREBLON)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		5 / 12 ASN A  50
PRO A  51
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.57A 6h0fB-4v30A:
19.6
6h0fC-4v30A:
undetectable		 6h0fB-4v30A:
21.09
6h0fC-4v30A:
16.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H0F_E_Y70E502_0
(IKAROS (IKZF1)
PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		8 / 12 ASN B 353
PRO B 354
HIS B 355
HIS B 380
TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-4.5A)
LVY  B1429 (-4.0A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.43A 6h0fE-4ci2B:
29.8
6h0fF-4ci2B:
undetectable		 6h0fE-4ci2B:
46.28
6h0fF-4ci2B:
4.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H0F_E_Y70E502_0
(IKAROS (IKZF1)
PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		6 / 12 GLU B 379
HIS B 380
TRP B 382
TRP B 388
TRP B 402
PHE B 404
 None
LVY  B1429 (-4.0A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.95A 6h0fE-4ci2B:
29.8
6h0fF-4ci2B:
undetectable		 6h0fE-4ci2B:
46.28
6h0fF-4ci2B:
4.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6H0F_E_Y70E502_0
(IKAROS (IKZF1)
PROTEIN CEREBLON)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		5 / 12 ASN A  50
PRO A  51
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.57A 6h0fE-4v30A:
0.0
6h0fF-4v30A:
undetectable		 6h0fE-4v30A:
21.09
6h0fF-4v30A:
16.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H0F_H_Y70H502_0
(IKAROS (IKZF1)
PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		8 / 12 ASN B 353
PRO B 354
HIS B 355
HIS B 380
TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-4.5A)
LVY  B1429 (-4.0A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.42A 6h0fH-4ci2B:
29.9
6h0fI-4ci2B:
undetectable		 6h0fH-4ci2B:
46.28
6h0fI-4ci2B:
4.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H0F_H_Y70H502_0
(IKAROS (IKZF1)
PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		6 / 12 GLU B 379
HIS B 380
TRP B 382
TRP B 388
TRP B 402
PHE B 404
 None
LVY  B1429 (-4.0A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.93A 6h0fH-4ci2B:
29.9
6h0fI-4ci2B:
undetectable		 6h0fH-4ci2B:
46.28
6h0fI-4ci2B:
4.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6H0F_H_Y70H502_0
(IKAROS (IKZF1)
PROTEIN CEREBLON)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		5 / 12 ASN A  50
PRO A  51
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.57A 6h0fH-4v30A:
0.0
6h0fI-4v30A:
undetectable		 6h0fH-4v30A:
21.09
6h0fI-4v30A:
16.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H0F_K_Y70K502_0
(IKAROS (IKZF1)
PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		8 / 12 ASN B 353
PRO B 354
HIS B 355
HIS B 380
TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-4.5A)
LVY  B1429 (-4.0A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.43A 6h0fK-4ci2B:
29.7
6h0fL-4ci2B:
undetectable		 6h0fK-4ci2B:
46.28
6h0fL-4ci2B:
4.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H0F_K_Y70K502_0
(IKAROS (IKZF1)
PROTEIN CEREBLON)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		6 / 12 GLU B 379
HIS B 380
TRP B 382
TRP B 388
TRP B 402
PHE B 404
 None
LVY  B1429 (-4.0A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.95A 6h0fK-4ci2B:
29.7
6h0fL-4ci2B:
undetectable		 6h0fK-4ci2B:
46.28
6h0fL-4ci2B:
4.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6H0F_K_Y70K502_0
(IKAROS (IKZF1)
PROTEIN CEREBLON)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		5 / 12 ASN A  50
PRO A  51
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.57A 6h0fK-4v30A:
0.0
6h0fL-4v30A:
undetectable		 6h0fK-4v30A:
21.09
6h0fL-4v30A:
16.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H0G_B_Y70B502_0
(PROTEIN CEREBLON
ZINC FINGER PROTEIN
692)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		8 / 11 ASN B 353
PRO B 354
HIS B 355
HIS B 380
TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-4.5A)
LVY  B1429 (-4.0A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.45A 6h0gB-4ci2B:
50.7
6h0gC-4ci2B:
undetectable		 6h0gB-4ci2B:
46.28
6h0gC-4ci2B:
8.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6H0G_B_Y70B502_0
(PROTEIN CEREBLON
ZINC FINGER PROTEIN
692)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		5 / 11 ASN A  50
PRO A  51
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.58A 6h0gB-4v30A:
0.0
6h0gC-4v30A:
undetectable		 6h0gB-4v30A:
21.09
6h0gC-4v30A:
14.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H0G_E_Y70E502_0
(PROTEIN CEREBLON
ZINC FINGER PROTEIN
692)		 4ci2 PROTEIN CEREBLON
(Gallus
gallus) 		9 / 12 ASN B 353
PRO B 354
HIS B 355
HIS B 380
SER B 381
TRP B 382
TRP B 388
TRP B 402
PHE B 404
 LVY  B1429 (-4.1A)
LVY  B1429 (-4.7A)
LVY  B1429 (-4.5A)
LVY  B1429 (-4.0A)
LVY  B1429 (-3.8A)
LVY  B1429 (-3.1A)
LVY  B1429 (-3.5A)
LVY  B1429 (-3.7A)
LVY  B1429 (-4.5A)
 0.34A 6h0gE-4ci2B:
50.4
6h0gF-4ci2B:
undetectable		 6h0gE-4ci2B:
46.28
6h0gF-4ci2B:
8.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6H0G_E_Y70E502_0
(PROTEIN CEREBLON
ZINC FINGER PROTEIN
692)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		6 / 12 ASN A  50
PRO A  51
SER A  78
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.0A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.53A 6h0gE-4v30A:
0.0
6h0gF-4v30A:
undetectable		 6h0gE-4v30A:
21.09
6h0gF-4v30A:
14.66